Data for Effects of NO Donor Therapy on the Dystrophic Mouse Muscle TCA Cycle (part VI) (Study ST000650)
(Analysis AN000982)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 | F5 | F6 |
---|---|---|---|---|---|---|
2-Hydroxyglutarate | 0.9980 | 0.9997 | 1.1391 | 1.1357 | 0.7574 | 0.9702 |
cis-Aconitic Acid | 1.0183 | 1.0096 | 1.1064 | 1.0536 | 0.8130 | 0.9992 |
Citrate | 1.0877 | 1.0698 | 1.1030 | 0.9120 | 0.8285 | 0.9990 |
Fumarate | 1.1390 | 1.1150 | 1.0554 | 0.8465 | 0.9080 | 0.9362 |
Isocitrate | 1.0868 | 0.8609 | 0.8741 | 1.2466 | 0.9504 | 0.9812 |
Ketoglutarate | 0.5275 | 0.4218 | 0.4686 | 3.6476 | 0.4064 | 0.5282 |
Lactate | 1.0196 | 0.9376 | 0.9605 | 0.9412 | 1.1574 | 0.9837 |
Malate | 1.1360 | 1.1247 | 1.0419 | 0.8521 | 0.9063 | 0.9390 |
Oxaloacetate | 1.0150 | 0.7773 | 1.2579 | 0.8464 | 1.0317 | 1.0717 |
Succinate | 1.3037 | 0.8499 | 0.9817 | 1.0356 | 0.8878 | 0.9412 |
Factors:
F1 | Time point:Post Run | Grouping:RUN-Naproxcinod |
F2 | Time point:Post Run | Grouping:RUN-Naproxen |
F3 | Time point:Post Run | Grouping:RUN-Vehicle |
F4 | Time point:Sedentary | Grouping:SED-Naproxcinod |
F5 | Time point:Sedentary | Grouping:SED-Naproxen |
F6 | Time point:Sedentary | Grouping:SED-Vehicle |